Lupus how long to live

The kidneys filter toxins from the body, and over time may be overwhelmed by the damaging effects of inflammation due to SLE. Fortunately, newer therapies have made this complication less common. Over time, dialysis or a transplant may be needed. Better long-term results are seen with a kidney transplant, and patients usually do quite well after a transplant. It is important to note that each person with SLE is unique and may experience different disease symptoms and severity. Patients with SLE have a higher risk for heart attack or stroke.

Cardiovascular disease is the most common reason for deaths related to SLE. It can also cause blood problems such as anemia and bleeding and clotting disorders. Lung problems are also common with SLE, and can lead to difficulty breathing. Other systems in the body can also be affected, including the brain, circulatory and digestive systems.

But it is hard to disentangle effects of severe disease from the effects of high dose steroids as the same patients are affected by both. We have demonstrated significantly increased levels of total cholesterol and triglycerides, and increased small, more atherogenic, LDL subfractions in SLE patients compared with controls.

There is also a higher level of lipid hydroperoxides consistent with oxidative stress in the SLE patients [ 20 ]. Bruce et al. Logistic regression analysis showed that the presence of plaque was independently associated with a previous coronary event, prolonged steroid use, older age, higher systolic blood pressure readings and higher LDL levels.

A previous coronary event, older age and high systolic blood pressure were associated with more severe plaque formation. Advice about not smoking, appropriate exercise, low cholesterol diets, lipid lowering therapy, control of blood pressure and screening for diabetes mellitus should be reviewed regularly.

Osteoporotic fractures are probably the most preventable form of musculoskeletal damage. The standardized morbidity ratio was 4. Kipen et al. There was a much clearer inverse relation between steroid use ever and the spine BMD result than the femoral neck BMD. Sinigaglia et al. Jardinet et al. In Birmingham we have studied patients, median age Ethnic group, steroid use and disordered menstrual history were associated with reduced BMD but not with fractures. Impaired mobility was strongly associated with low BMD and fractures on univariate analysis.

Multiple logistic regression showed that age was the best predictor of fractures with a modified DI score which excluded fractures as a damage item and osteoporotic BMD exerting less influence.

Impaired mobility and menopausal status were not independent predictors of fractures in our cohort [ 31 ]. Genetic and environmental factors contribute to the determination of bone mass and the risk of fracture. To reduce the risk of fracture, keep steroid doses as low as possible while controlling disease activity with the use of other immunosuppressive agents if necessary, encourage a good diet with appropriate physical activity and strongly advise against smoking, as for the prevention of cardiovascular disease.

They are retained in the body for long periods even after therapy has ceased and, in animal studies, have caused fetal abnormalities [ 32 ]. They should have completed their families or be considered too unwell to be likely to become pregnant in the future at least for several years and they should be regularly counselled against becoming pregnant on bisphosphonates.

For many years it has been said that lupus improves after the menopause and that HRT may exacerbate the disease or prevent this improvement. Unfortunately, the intranasal preparation, which is the most convenient for patients, may be hard to obtain compared with the subcutaneous form. The final topic for discussion, the risk of malignancy in SLE patients, is a less common problem than the issues discussed above.

But it is of considerable concern to lupus patients and is a subject often raised by them or by other physicians. If lupus patients develop a cancer or lymphoma, oncologists often blame immunosuppressive therapy, even if the patient has only been exposed to the therapy for a few months. However, there is no data to support the concept that steroids or cytotoxic agents are predisposing factors for malignancy in SLE patients, although there is in rheumatoid arthritis [ 35 ].

In lupus it is possible that disturbances in immune surveillance are associated with the risk of developing malignancy, as it is a disease characterized by immune system dysfunction. There have been a number of studies attempting to establish whether or not there is an increased risk of malignancy in SLE [ 37 ]. The SIR for malignancy in lupus patients is greater than 1. Interestingly, these three studies used cancer registry data, not just a review of medical notes and questionnaires.

Five studies have looked for a relationship to cytotoxic therapy and not found any association. Not addressed in these studies, but demonstrated separately, has been an increase in cervical dysplasia, usually associated with viral infection and not necessarily related to previous cytotoxic therapy [ 45 , 46 ]. It is important that women with lupus receive regular cervical screening to ensure that they do not develop cervical cancer. In Isenberg's cohort in London [ 43 ], there was no increase in malignancy compared with the local population overall, but there was an increase in Hodgkin's lymphoma.

Six patients out of followed between and had died from malignancy 2. Our experience in Birmingham is very similar unpublished observations. There have been 25 deaths within the study period. Thirteen malignancies were identified in the cohort, giving an overall standardized incidence ratio of 3.

The morbidity and mortality associated with SLE is still considerable despite improvements in initial immunosuppressive therapy for active disease. The lupus patients themselves need to understand why this is important and their own role in modifying lifestyle factors that increase the risks of cardiovascular disease and osteoporosis in particular. Correspondence to: C. Mortality studies in systemic lupus erythematosus. Results from a single center. Causes of death. J Rheumatol ; 22 : — Improved survival over 24 years.

J Rheumatol ; 24 : —5. Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol ; 13 : — Assessing patients with lupus: towards a drug responder index. Rheumatology ; 38 : —9. Inflammation of the lining around the heart can also cause chest pain pericarditis. People with lupus have a greater likelihood of developing anemia or blood clots.

Some people with lupus also have antiphospholipid antibody syndrome APS. APS increases the risk of developing blood clots and miscarriages. Sometimes, the inflammation occurs in the brain. This can cause headaches, mental problems like memory loss or poor concentration, seizures, meningitis, or even a coma. Some lupus patients also experience changes in their mood, particularly with irritability, depression, and anxiety.

Some lupus patients develop inflammation in the lining around the lungs. This is called pleuritis. It causes sharp chest pains when you inhale. If the inflammation spreads to the lungs themselves, they can become scarred.

Lung scarring decreases the amount of oxygen that the bloodstream absorbs. People with lupus commonly have inflammatory arthritis. They wake up in the morning with stiffness and swelling in their joints, usually in the small joints of the hands. Unlike some other forms of arthritis, inflammatory arthritis from lupus rarely deforms the hands. Other steps you can take include:. Your doctor may also recommend certain lifestyle changes to help you better control your lupus, such as eating a healthy diet, exercising, not smoking, and resting when you are tired.

By providing your email address, you are agreeing to our privacy policy. We never sell or share your email address. All rights reserved.

Always consult your doctor about your medical conditions. Use of the site is conditional upon your acceptance of our terms of use. Lupus Life Expectancy. By Editorial Team November 15, Share to Facebook Share to Twitter email print page Bookmark for later.